News

A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money
Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street. Investors looking to strike ...
BioWorld3d
Biocon wins first FDA interchangeable label of Novolog biosimilar
The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable ...
Zacks Investment Research on MSN3d
Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?
Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...
gut.bmj5d
Non-invasive tests of fibrosis in the management of MASLD: revolutionising diagnosis, progression and regression monitoring
VW-SW served as a consultant or advisory board member for AbbVie, Boehringer Ingelheim, Echosens, Gilead Sciences, Intercept, Inventiva, Novo Nordisk, Pfizer, Sagimet Biosciences, TARGET ...
Stockhead5d
Big pharma takes notice as Novo Nordisk puts Clever Culture’s APAS to the test
Clever Culture’s APAS is now on trial with Novo Nordisk, and if it delivers, this one machine could unlock a global pharma ...
Zacks Investment Research on MSN5d
Novo Nordisk Plunges 20% YTD: How Should Investors Play the Stock?
Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...